Indeed, SOX2OT was detected inside EVs from NSCLC cells and associated with the induction of an M2-like phenotype and concomitant M1 polarization inhibition through the miR-627-3p/SMAD signalling pathway, resulting in increased EGFR-TKI resistance. The gene discussed is SOX2-OT; the disease is non-small cell lung carcinoma.